National Comprehensive Cancer Network Inc
- Assets
- $114.9m
- Revenue
- $46.2m
- Investments
- $0.0
- Employees
- 173
- Location
- Plymouth Meeting, PA
- Founding
- 03/1997
- Data as of
- 12/2021
- EIN
- 23-2818395
Organization Overview
National Comprehensive Cancer Network Inc is located in Plymouth Meeting, PA. The organization was established in 1997. According to its NTEE Classification (E99) the organization is classified as: Health Care N.E.C., under the broad grouping of Health Care and related organizations. As of 12/2022, National Comprehensive Cancer Network Inc employed 173 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. National Comprehensive Cancer Network Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, National Comprehensive Cancer Network Inc generated $46.2m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 6.8% each year. All expenses for the organization totaled $30.2m during the year ending 12/2021. While expenses have increased by 3.2% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, National Comprehensive Cancer Network Inc has awarded 188 individual grants totaling $19,991,391. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
NCCN IS DEDICATED TO IMPROVING AND FACILITATING QUALITY, EFFECTIVE, EQUITABLE, AND ACCESSIBLE CANCER CARE SO ALL PATIENTS CAN LIVE BETTER LIVES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
NCCN GUIDELINES, NCCN CONTENT & EDUCATIONAL PROGRAMS:WITH EXPERTS FROM MAJOR ACADEMIC CANCER CENTERS, DEVELOP AND UPDATE CLINICAL PRACTICE GUIDELINES FOR TREATMENT OF CANCER; INCLUDES BOTH DISTRIBUTION OF GUIDELINES FOR NON-COMMERCIAL USE AS WELL AS CERTAIN EDUCATIONAL CONFERENCES AND SYMPOSIA TO COMMUNICATE CONTENT FREE OF CHARGE.
DEVELOPMENT OF OTHER PUBLIC AND PROFESSIONAL INFORMATION PROGRAMS TO FACILITATE ACCESS TO CANCER SPECIALTY SERVICES.
PATIENT INFORMATION:DISSEMINATION OF PATIENT INFORMATION BASED ON GUIDELINES; DEVELOPMENT AND DISSEMINATION OF MEASURES TO ASSESS THE QUALITY OF CARE.
ONCOLOGY RESEARCH:DEVELOPMENT OF A CLINICAL RESEARCH NETWORK OF PHYSICIANS AT MEMBER ACADEMIC CANCER CENTERS TO FACILITATE THE CONDUCT OF STUDIES TO ADVANCE STATE-OF-THE-ART CANCER CARE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
John W Sweetenham MD Facp Frcp Director, Chair | Trustee | 2 | $0 |
Matt Kalaycio MD Director, Vice-Chair | Trustee | 2 | $0 |
Rebecca L Caires MBA Director | Trustee | 2 | $0 |
Patrick J O'brien MBA Director, Treasurer | Trustee | 2 | $0 |
Robert H Vonderheide MD Dphil Director | Trustee | 2 | $0 |
Robin Famiglietti PHD MBA Fache Director | Trustee | 2 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Clinical Care Options Llc Medical Education Program Services | 12/30/22 | $1,657,443 |
Health Research Inc Research | 12/30/22 | $365,696 |
Itc Translations Usa Inc Professional Services | 12/30/22 | $574,358 |
Alcom Printing Group Inc Fulfillment - Shipping & Postage | 12/30/22 | $327,915 |
Morgan Lewis & Bockius Llp Legal | 12/30/22 | $326,687 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $4,340,000 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $14,955,605 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $19,295,605 |
| Total Program Service Revenue | $23,520,158 |
| Investment income | $1,382,823 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $1,757,183 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $46,211,501 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $1,828,373 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $2,573,584 |
| Compensation of current officers, directors, key employees. | $572,554 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $13,902,946 |
| Pension plan accruals and contributions | $834,626 |
| Other employee benefits | $3,103,675 |
| Payroll taxes | $1,030,333 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $271,907 |
| Fees for services: Accounting | $74,750 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $930,407 |
| Advertising and promotion | $117,748 |
| Office expenses | $249,677 |
| Information technology | $805,322 |
| Royalties | $0 |
| Occupancy | $1,939,019 |
| Travel | -$29,543 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $806,069 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $445,692 |
| Insurance | $182,781 |
| All other expenses | $224,149 |
| Total functional expenses | $30,230,411 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $28,525,911 |
| Savings and temporary cash investments | $12,338,596 |
| Pledges and grants receivable | $5,698,774 |
| Accounts receivable, net | $1,570,910 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $338,510 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $1,242,211 |
| Net Land, buildings, and equipment | $1,783,434 |
| Investments—publicly traded securities | $63,414,570 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $114,912,916 |
| Accounts payable and accrued expenses | $3,614,196 |
| Grants payable | $0 |
| Deferred revenue | $20,728,151 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $24,342,347 |
| Net assets without donor restrictions | $86,892,520 |
| Net assets with donor restrictions | $3,678,049 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $114,912,916 |
Grants Awarded
Over the last fiscal year, National Comprehensive Cancer Network Inc has awarded $1,870,432 in support to 24 organizations.
| Grant Recipient | Amount |
|---|---|
ADVENTHEALTH ORLANDO PURPOSE: RESEARCH | $14,392 |
H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE PURPOSE: RESEARCH | $71,960 |
CITY OF HOPE COMP CANCER CTR PURPOSE: RESEARCH | $75,000 |
FOX CHASE CANCER CENTER PURPOSE: RESEARCH | $158,980 |
HEALTH RESEARCH INC PURPOSE: RESEARCH | $365,696 |
MASS GENERAL HOSPITAL PURPOSE: RESEARCH | $155,070 |